CNR Institutional Research Information System

OLLA, STEFANIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 1.106
NA - Nord America 585
EU - Europa 408
SA - Sud America 104
AF - Africa 13
OC - Oceania 6
Totale 2.222
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 555
SG - Singapore 540
IT - Italia 234
CN - Cina 136
VN - Vietnam 94
BR - Brasile 85
HK - Hong Kong 77
ID - Indonesia 49
BD - Bangladesh 44
NL - Olanda 43
FR - Francia 39
TH - Thailandia 35
JP - Giappone 24
IN - India 18
PH - Filippine 18
DE - Germania 17
GB - Regno Unito 17
MY - Malesia 17
FI - Finlandia 16
KR - Corea 15
CA - Canada 10
MX - Messico 9
TR - Turchia 8
AR - Argentina 6
CO - Colombia 6
ES - Italia 6
ZA - Sudafrica 6
AT - Austria 5
AU - Australia 5
IL - Israele 5
SE - Svezia 5
AE - Emirati Arabi Uniti 4
AL - Albania 4
JM - Giamaica 4
SA - Arabia Saudita 4
CR - Costa Rica 3
IQ - Iraq 3
PL - Polonia 3
UZ - Uzbekistan 3
BE - Belgio 2
CL - Cile 2
GE - Georgia 2
KE - Kenya 2
KZ - Kazakistan 2
LT - Lituania 2
PK - Pakistan 2
RO - Romania 2
TT - Trinidad e Tobago 2
UA - Ucraina 2
UY - Uruguay 2
AZ - Azerbaigian 1
CZ - Repubblica Ceca 1
DK - Danimarca 1
DZ - Algeria 1
EC - Ecuador 1
EG - Egitto 1
HN - Honduras 1
HR - Croazia 1
IE - Irlanda 1
KG - Kirghizistan 1
LB - Libano 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
LY - Libia 1
MD - Moldavia 1
MM - Myanmar 1
MW - Malawi 1
NI - Nicaragua 1
NZ - Nuova Zelanda 1
OM - Oman 1
PE - Perù 1
PT - Portogallo 1
PY - Paraguay 1
RS - Serbia 1
RU - Federazione Russa 1
SK - Slovacchia (Repubblica Slovacca) 1
TZ - Tanzania 1
Totale 2.222
Salva come PNG Salva come JPEG
Città #
Singapore 318
Santa Clara 96
San Jose 80
Hong Kong 76
Ashburn 71
Assemini 45
Jakarta 42
Beijing 39
Ho Chi Minh City 38
Los Angeles 38
Bangkok 35
Hefei 30
Lauterbourg 30
Hanoi 23
Tokyo 21
New York 19
Manila 17
Tito 16
Cagliari 14
Dallas 14
Milan 14
Seoul 14
Buffalo 12
Amsterdam 11
Kuala Selangor 11
Lappeenranta 11
Rome 10
São Paulo 10
Council Bluffs 9
Phoenix 9
Florence 8
Houston 8
Brooklyn 7
Kuala Lumpur 6
London 6
Boston 5
Helsinki 5
Johannesburg 5
Monza 5
Naples 5
Stockholm 5
Camporotondo Etneo 4
Chicago 4
Frankfurt am Main 4
Haiphong 4
Kingston 4
Mexico City 4
Tampa 4
Ankara 3
Bengaluru 3
Boardman 3
Bologna 3
Can Tho 3
Charlotte 3
Chennai 3
Dammam 3
Düsseldorf 3
Elk Grove Village 3
Manchester 3
Medellín 3
Montreal 3
Orem 3
San Gregorio di Catania 3
San José 3
Surabaya 3
Sydney 3
Tashkent 3
Toronto 3
Turin 3
Virginia Beach 3
Warsaw 3
Acalanes Ridge 2
Antioch 2
Arlington 2
Assis 2
Atlanta 2
Avellino 2
Bari 2
Belo Horizonte 2
Brussels 2
Busto Arsizio 2
Camaçari 2
Chaguanas 2
Chico 2
Curitiba 2
Da Nang 2
Denver 2
Dhaka 2
Dongguan 2
Duque de Caxias 2
Feltre 2
Istanbul 2
Lahore 2
Malappuram 2
Meriden 2
Minamishinagawa 2
Montevideo 2
Mumbai 2
Nairobi 2
Nam Định 2
Totale 1.393
Salva come PNG Salva come JPEG
Nome #
An USH2A founder mutation is the cause of Usher syndrome type 2 in Sardinia 455
COMPOUNDS FOR USE IN PROGRESSIVE MULTIPLE SCLEROSIS 103
A large-scale screening identified in USH2A gene the P3272L founder pathogenic variant explaining familial Usher syndrome in Sardinia, Italy 96
Dissection of the BAFF pathway in Multiple Sclerosis with a view toward more specific and effective therapies 90
Complex genetic signatures in immune cells underlie autoimmunity and inform therapy 82
Overexpression of the Cytokine BAFF and Autoimmunity Risk 82
A Sardinian founder mutation in glycoprotein Ib platelet subunit beta(GP1BB) that impacts thrombocytopenia 74
1-[(3-Aryloxy-3-aryl)propyl]-1H-imidazoles, new imidazoles with potent activity against Candida albicans and dermatophytes. Synthesis, structure-activity relationship, and molecular modeling studies 68
Combining human genetics of multiple sclerosis with oxidative stress phenotype for drug repositioning 64
Inhibitory Effect of Quercetin on Oxidative Endogen Enzymes: A Focus on Putative Binding Modes 63
The Antioxidant Drug Edaravone Binds to the Aryl Hydrocarbon Receptor (AHR) and Promotes the Downstream Signaling Pathway Activation 63
Rational design of new candidate compounds for multiple sclerosis treatment based on analysis of biological targets identified through genome wide association studies in Sardinia. 61
Genetic variants regulating immune cell levels in health and disease. 61
Bioinformatics and cell reprogramming to develop an in vitro platform to discover new drugs for progressive multiple sclerosis (BRAVEinMS) 57
System and pathway analysis of variants associated with immune cell levels 57
Confirmation of a new phenotype in an individual with a variant in the last part of exon 30 of CREBBP 51
Exploring Asphodelus microcarpus as a source of xanthine oxidase inhibitors: Insights from in silico and in vitro studies 49
Synthesis and Characterization of Edaravone Analogues as Remyelinating Agents and Putative Mechanistic Probes 49
Genetic-Driven Druggable Target Identification and Validation 48
Oxidative Status in Multiple Sclerosis and Off-Targets of Antioxidants: The Case of Edaravone 47
Substituted 2-pyrrolinone compounds as inhibitors of B-cell activating factor (BAFF) for autoimmune diseases treatment 46
Biological Potential of Asphodelus microcarpus Extracts: α-Glucosidase and Antibiofilm Activities In Vitro 46
Rational design and synthesis of edaravone- remyelinating analogues and probes: a preliminary SAR 41
MMsDusty: an Alternative InChI-Based Tool to Minimize Chemical Redundancy 37
Identification and validation of edaravone remyelinating targets in oligodendrocyte progenitor cells 36
OTULIN-related conditions: Report of a new case and review of the literature using GenIA 36
An Alternative QSAR-Based Approach for Predicting the Bioconcentration Factor for Regulatory Purposes 36
Pharmacophore modelling: A continuously evolving tool for computational drug design 34
Molecular Similarity in Computational Toxicology 34
Overlapping syndromes in laminopathies: A meta-analysis of the reported literature 32
Phage Display Selection and In Silico Characterization of Peptides as Potential GroEL Modulators 32
A staged screening of registered drugs highlights remyelinating drug candidates for clinical trials 31
Anomalous transport and relaxation in classical one-dimensional models 31
Indolyl-pyrrolone as a new scaffold for Pim1 inhibitors. 29
An Alternative QSAR-Based Approach for Predicting the Bioconcentration Factor for Regulatory Purposes 27
The Anti-Angiogenic Effect of Cynara cardunculus L. subsp. cardunculus Waste Product 26
Indolyl-pyrrolone as a new scaffold for Pim1 inhibitors 22
Drugs Repurposing of Molecules Modulating Human Delta Globin Gene Expression via a Model of Transgenic Foetal Liver Cells: Implications for Beta-Hemoglobinopathy Therapeutics 21
Genetic co-regulation of neopterin and Parkinson’s disease 19
null 12
Totale 2.348
Salva come PNG Salva come JPEG
Categoria #
all - tutte 6.456
article - articoli 4.532
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 288
Totale 11.276
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202418 0 0 0 0 0 0 0 0 2 6 5 5
2024/2025687 1 2 43 20 120 70 59 55 53 33 125 106
2025/20261.600 54 83 295 240 265 89 226 49 49 103 86 61
2026/202743 43 0 0 0 0 0 0 0 0 0 0 0
Totale 2.348